De novo somatic mutations and KRAS amplification are associated with cholangiocarcinoma in a patient with a history of choledochal cyst

Marisa E. Schwab, Hanbing Song, Aras Mattis, Andrew Phelps, Lan T. Vu, Franklin W. Huang, Amar Nijagal

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Background/Purpose: Choledochal cysts are congenital dilations of the bile ducts, and are associated with an increased risk of malignant transformation. The purpose of this study is to report the outcomes of a large series of patients with choledochal cysts and to highlight our analysis of one patient who developed malignancy after cyst resection. Methods: We conducted a retrospective review of patients < 18 years of age with a choledochal cyst who underwent surgical resection between 1995 and 2018. Molecular testing of resected choledochal cyst specimens using the UCSF500 gene panel was performed on three patients including a 3-month-old boy and a 7-year-old girl who have remained cancer-free, and a 16-year-old girl who subsequently developed cholangiocarcinoma less than two years after resection. Results: One patient of the 48 included in our study developed cholangiocarcinoma after choledochal cyst resection. We observed de novo somatic mutations in TP53 and RBM10, and KRAS amplification in this patient's tumor. Conclusions: In our series, the rate of malignancy after choledochal cyst resection was low. One patient developed de novo mutations in the remnant bile ducts after cyst resection. While it is a rare occurrence, the risk of malignancy following cyst resection supports the need for lifelong surveillance. Level of evidence: IV

Original languageEnglish (US)
Pages (from-to)2657-2661
Number of pages5
JournalJournal of pediatric surgery
Volume55
Issue number12
DOIs
StatePublished - Dec 2020
Externally publishedYes

Keywords

  • Cholangiocarcinoma
  • Choledochal cysts
  • KRAS
  • Molecular genetics

ASJC Scopus subject areas

  • Surgery
  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'De novo somatic mutations and KRAS amplification are associated with cholangiocarcinoma in a patient with a history of choledochal cyst'. Together they form a unique fingerprint.

Cite this